The Journal of Clinical Investigation, 2020 · DOI: https://doi.org/10.1172/JCI125771 · Published: March 16, 2020
After trauma, regeneration of adult CNS axons is abortive, causing devastating neurologic deficits. Despite progress in rehabilitative care, there is no effective treatment that stimulates axonal growth following injury. Using models with different regenerative capacities, followed by gain- and loss-of-function analysis, we identified profilin 1 (Pfn1) as a coordinator of actin and microtubules (MTs), powering axonal growth and regeneration. In vivo, Pfn1 ablation limited regeneration of growth-competent axons after sciatic nerve and spinal cord injury. Adeno-associated viral (AAV) delivery of constitutively active Pfn1 to rodents promoted axonal regeneration, neuromuscular junction maturation, and functional recovery of injured sciatic nerves, and increased the ability of regenerating axons to penetrate the inhibitory spinal cord glial scar.
Pfn1 is identified as a therapeutic target for promoting axonal regeneration upon injury.
AAV-mediated delivery of constitutively active Pfn1 shows promise for treating nervous system injuries.
Identifying modulators of Pfn1 activity could enhance therapeutic potential for axonal regeneration.